Breaking News

Amgen and AstraZeneca Present Groundbreaking Oncology Data at ESMO, Demonstrating a 58% Reduction in Risk of Death for Small Cell Lung Cancer

Amgen and AstraZeneca presented practice-changing Phase 3 clinical data at the European Society for Medical Oncology (ESMO) 2026 Congress, demonstrating that frontline maintenance therapy combining Imdelltra (tarlatamab-dlle)and Imfinzi (durvalumab) cut the risk of...

​Next-Generation MAKO 4 Robotic-Assisted Surgery System Officially Launched to Advance Precision in Joint Replacement

In a major development for orthopedic surgical technology, medical device innovators and surgical teams have celebrated the official rollout of...

​Indian Pharmacopoeia Commission Issues Drug Safety Alert Linking Levetiracetam and Topical Decongestants to Specific Adverse Reactions

The Indian Pharmacopoeia Commission (IPC), functioning as the National Coordination Centre for the Pharmacovigilance Programme of India (NCC-PvPI)...

Rising Yields Hit Sun Pharma’s Fundraising Drive as Bond Issue Misses ₹10,000 Crore Goal

India’s largest drugmaker by market capitalisation Sun Pharmaceutical Industries has raised ₹7,816 crore (~8000 cr) against its ₹10,000-crore fundraising target, highlighting the growing...

GLP-1 Boom: China, India and Brazil Could Unlock a $22 Billion Market by 2035 , J.P. Morgan Estimates

The market for GLP-1 medicines across China, India and Brazil could surge from $6.6 billion currently to $22 billion...

Ayushman Arogya Mandirs, Digital Health & Inclusive NHM Progress Highlighted in 17th CRM Findings

The two-day 10th National Summit on Innovation and Inclusivity, organised under the National Health Mission (NHM), concluded with a strong emphasis on evidence-based reforms,...

Dr. Reddy’s Makes History with Health Canada Approval of World’s First Generic Semaglutide Injection in a G7 Market

Dr. Reddy’s Laboratories Ltd.a leading global pharmaceutical company, is pleased to announce it has received a Notice of Compliance (NOC) from Health Canada for...

Union Health Minister J. P. Nadda Reviews NIPER Mohali’s Innovation Pipeline, Inaugurates Medicinal Succulents Garden

Union Minister for Health and Family Welfare and Chemicals & Fertilizers, Shri J. P. Nadda, visited the National Institute of Pharmaceutical Education and Research...

UGC-NET 2026 Expansion: Statistics Entry Set to Power Healthcare Analytics, Epidemiology & Medical Research Careers

In a significant academic reform with far-reaching implications for healthcare, pharmaceutical research, and public health innovation, the University Grants Commission (UGC) has officially introduced...

Eli Lilly Expands Oncology Ambitions with Up to $2.3 Billion Ajax Therapeutics Acquisition

Eli Lilly has announced a major strategic move to strengthen its oncology portfolio through the acquisition of Ajax Therapeutics in a deal valued at...

India–New Zealand FTA Opens Zero-Duty Pharma Gateway, Boosting ‘Made in India’ Healthcare Exports

In a significant boost for India’s healthcare and pharmaceutical ecosystem, the newly signed India–New Zealand Free Trade Agreement (FTA) is set to create powerful...